Thank you for continuing to be part of the Ascendia Clinical community. As we moved through Q2, one theme remained clear: sponsors and clinical teams are being asked to do more with greater precision, stronger oversight, and fewer delays.
This quarter, our conversations focused on practical execution across clinical operations, quality, vendor oversight, and emerging technology. Teams are looking for ways to reduce complexity while maintaining control over the decisions that matter most.
In this edition, we highlight key areas from Q2, including flexible support models, the experience behind Ascendia’s work, ongoing conversations from The Clinical Current, and the evolving role of AI in clinical operations.
As AI becomes more visible across the clinical trial landscape, the opportunity is real—but so is the responsibility. The greatest value will come from pairing new tools with experienced judgment, secure processes, and clear decision-making.
Looking ahead, Ascendia Clinical remains focused on helping sponsors strengthen execution, manage risk, and move forward with confidence.
Ascendia Clinical
.webp)
Across clinical development, AI is quickly moving from a future-facing idea to a practical tool for improving efficiency, visibility, and decision-making.
As interest grows, teams are asking more focused questions: where does AI fit, how should it be governed, what data can it safely access, and how should outputs be reviewed?
This shift marks a more responsible phase of AI adoption—one centered on oversight, validation, and human judgment.
For sponsors, the opportunity is not to replace experienced clinical leadership, but to strengthen it. With the right controls in place, AI can help teams organize complexity, surface insights faster, and support better decisions. Ascendia Clinical remains focused on helping teams balance innovation with clarity, control, and compliance.
Chris is the principal consultant and founder of QACV Consulting, a compliance, quality assurance, and computer systems validation consulting firm supporting regulated industry organizations.
With more than 30 years of experience, he brings deep expertise in compliance, data integrity, auditing, training, and quality improvement.
As a trusted community partner and resource to Ascendia, Chris and the compliance team at QACV consultants provide a valuable perspective on quality, compliance, and technology-driven operational excellence in QA and regulatory compliance.
In this special three-year anniversary episode of Clinical Current, Teresa Hines is joined by Ascendia co-founders Amy Klawitter and Ron Cherubin to discuss Ascendia FLEX—why it was created, how it supports sponsors across Assist, Core, and Plus models, and how flexible expertise helps teams stay agile without sacrificing quality or control.
AI is quickly becoming part of the clinical trial conversation, but the question for sponsors is no longer whether AI has potential. The more important question is where it can create measurable value without adding confusion, risk, or unnecessary complexity.
In Maximizing the Value of AI in Clinical Trials: Where to Focus First, Ascendia Clinical explores why AI adoption often stalls when teams try to apply it too broadly or without clear operational direction. The article emphasizes the importance of starting with assessment: identifying where time is being lost, where manual review is slowing progress, and where critical signals may be difficult to see.
From there, the focus shifts to practical implementation. AI is most valuable when it is connected to clear use cases, integrated into existing workflows, and supported by trained teams who know how to validate, interpret, and act on its outputs.
For sponsors and clinical teams, the takeaway is clear: AI works best when it strengthens operational discipline. With the right strategy, oversight, and human expertise in place, it can help improve visibility, consistency, and decision-making across clinical trial operations.
Ascendia Clinical delivers expert consulting solutions for the Biotechnology and Pharmaceutical industries, with a focus on integrity, collaboration, and results. Partner with us for tailored strategies that drive your success.
